Загрузка...
A review of the safety and efficacy of nebivolol in the mildly hypertensive patient
Nebivolol is a third generation beta-blocker, which can be distinguished from other beta-blockers by its hemodynamic profile. It combines beta-adrenergic blocking activity with a vasodilating effect mediated by the endothelial L-arginine nitric oxide (NO) pathway. The effects of nebivolol have been...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2007
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2350132/ https://ncbi.nlm.nih.gov/pubmed/18200810 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|